Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 31 Records) |
Query Trace: Body Weight and VKORC1[original query] |
---|
Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients. European journal of clinical pharmacology 2007 Dec 63 (12): 1135-41. Miao Liyan, Yang Jian, Huang Chenrong, Shen Zhen |
Genetic factors contribute to patient-specific warfarin dose for Han Chinese. Clinica chimica acta; international journal of clinical chemistry 2008 Oct 396 (1-2): 76-9. Wang Ting-Liang, Li Hong-Lei, Tjong Wen-Ye, Chen Qian-Su, Wu Guan-Sheng, Zhu Hai-Tao, Hou Zi-Shan, Xu Shu, Ma Sheng-Jun, Wu Madeline, Tai Sus |
Pharmacogenetic testing for guiding de novo phenprocoumon therapy in stroke patients. Cerebrovascular diseases (Basel, Switzerland) 2009 28 (5): 468-71. Arnold Marie-Luise, Grond-Ginsbach Caspar, Kloss Manja, Di Mascio Maria-Teresa, Veltkamp Roland, Ringleb Peter, Lichy Christo |
Effect of VKORC1-1639 G>A polymorphism, body weight, age, and serum albumin alterations on warfarin response in Japanese patients. Thrombosis research 2009 Jun 124 (2): 161-6. Yoshizawa Misa, Hayashi Hideki, Tashiro Yoshio, Sakawa Sonoko, Moriwaki Hideaki, Akimoto Takehide, Doi Osamu, Kimura Midori, Kawarasaki Yoshinori, Inoue Kazuyuki, Itoh Kunihi |
VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weight, and age are important predictors for warfarin maintenance doses in patients with mechanical heart valve prostheses in southwest China. European journal of clinical pharmacology 2010 Dec 66 (12): 1217-27. Gu Qiang, Kong Yan, Schneede Jörn, Xiao Ying-Bin, Chen Lin, Zhong Qian-Jin, Wang Xue-Feng, Hao Jia, Chen Bai-Cheng, Chen Jing-J |
Contribution of 1173C > T polymorphism in the VKORC1 gene to warfarin dose requirements in Han Chinese patients receiving anticoagulation. International journal of clinical pharmacology and therapeutics 2011 Jan 49 (1): 23-9. Yang J, Huang C, Shen Z, Miao |
Multivariate analysis of the relation between diet and warfarin dose. European journal of clinical pharmacology 2012 Mar 68 (3): 321-8. Rasmussen Morten Arendt, Skov Jane, Bladbjerg Else-Marie, Sidelmann Johannes J, Vamosi Marianne, Jespersen Jørg |
Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians. BMC medical genetics 2011 12 80. Suriapranata Ivet M, Tjong Wen Ye, Wang Tingliang, Utama Andi, Raharjo Sunu B, Yuniadi Yoga, Tai Susan |
Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients. European journal of clinical pharmacology 2011 May . Shrif NE, Won HH, Lee ST, Park JH, Kim KK, Kim MJ, Kim S, Lee SY, Ki CS, Osman IM, Rhman EA, Ali IA, Idris MN, Kim JW |
A pharmacokinetic-pharmacodynamic model for predicting the impact of CYP2C9 and VKORC1 polymorphisms on fluindione and acenocoumarol during induction therapy. Clinical pharmacokinetics 2012 Jan 51 (1): 41-53. Verstuyft Céline, Delavenne Xavier, Rousseau Alexandra, Robert Annie, Tod Michel, Diquet Bertrand, Lebot Martine, Jaillon Patrice, Becquemont Laure |
Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation. Clinical therapeutics 2011 Oct 33 (10): 1371-80. Cho Hyun-Jung, On Young-Keun, Bang Oh Young, Kim Jong-Won, Huh Wooseong, Ko Jae-Wook, Kim June Soo, Lee Soo-Yo |
White blood cells contribute to patient-specific warfarin dose for Han Chinese. Chinese medical journal 2012 Jun 125 (11): 1960-3. Zhu Jin, Zheng Wen-Jie, Zhang Wei-Juan, Wang He-Yao, Wang Ch |
The combined effects of clinical factors and CYP2C9 and VKORC1 gene polymorphisms on initiating warfarin treatment in patients after cardiac valve surgery. The Journal of heart valve disease 2012 Sep 21 (5): 5. Tatar?nas V, Lesauskaite V, Veikutiene A, Grybauskas P, Jakuska P, Benetis R |
Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population. European journal of clinical pharmacology 2014 Jan 70 (1): 47-56. Krishna Kumar Dhakchinamoorthi, Shewade Deepak Gopal, Loriot Marie-Anne, Beaune Philippe, Balachander Jayaraman, Sai Chandran B V, Adithan Chandrasekar |
Quantifying the effect of covariates on concentrations and effects of steady-state phenprocoumon using a population pharmacokinetic/pharmacodynamic model. Clinical pharmacokinetics 2013 May 52 (5): 359-71. Abduljalil Khaled, Lazar Simone, Natanzon Michael, Wu Weidong, Zadoyan Gregor, Steffens Benedict, Kohl Victoria, Mörike Klaus, Tomalik-Scharte Dorota, Stingl Julia, Schwab Matthias, Harenberg Job, Gleiter Christoph, Fuhr U |
Prediction of warfarin maintenance dose in Han Chinese patients using a mechanistic model based on genetic and non-genetic factors. Clinical pharmacokinetics 2013 Jul 52 (7): 567-81. Lu Yuan, Yang Jinbo, Zhang Haiyan, Yang J |
[Personalized drug therapy-directed clinical pharmacology research based on genetic polymorphisms and pharmacokinetics analysis]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2013 133 (10): 1079-85. Hayashi Hide |
CYP2C9, VKORC1, CYP4F2, ABCB1 and F5 variants: influence on quality of long-term anticoagulation. Pharmacological reports : PR 2014 Apr 66 (2): 243-9. Nahar Risha, Saxena Renu, Deb Roumi, Parakh Rajiv, Shad Sujay, Sethi Prahlad K, Takkar Parul, Verma Ishwar |
[Influence of warfarin related genes and non- genetic factors on administrative dose in Shanghai area]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2014 Jan 35 (1): 13-7. Zhuang Wenfang, Wu Depei, Wang Zhaoy |
Effect of CYP2C9, CYP4F2 and VKORC1 genetic polymorphisms on pharmacokinetics and pharmacodynamics of mean daily maintenance dose of warfarin in Chinese patients. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2015 Mar 26 (2): 167-74. Zhuang Wenfang, Wen Wei, Xuan Binbin, Chen Yanhong, Cao Yanan, Sun Zhixin, Ma J |
CYP2C19*17 affects R-warfarin plasma clearance and warfarin INR/dose ratio in patients on stable warfarin maintenance therapy. European journal of clinical pharmacology 2015 Apr 71 (4): 433-9. Chang Ming, Söderberg Mao Mao, Scordo Maria Gabriella, Tybring Gunnel, Dahl Marja-Lii |
Warfarin dosage response related pharmacogenetics in Chinese population. PloS one 2015 10 (1): e0116463. Li Siyue, Zou Yuangao, Wang Xia, Huang Xunbei, Sun Yong, Wang Yuqing, Dong Li, Jiang Ho |
Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms. The pharmacogenomics journal 2016 Aug . Kubo K, Ohara M, Tachikawa M, Cavallari L H, Lee M T M, Wen M S, Scordo M G, Nutescu E A, Perera M A, Miyajima A, Kaneko N, Pengo V, Padrini R, Chen Y T, Takahashi |
A model analysis for dose-response relationship of warfarin in Japanese children: An introduction of the SIZE parameter. Drug metabolism and pharmacokinetics 2016 Apr . Nakamura Saki, Watanabe Nao, Yoshimura Naoki, Ozawa Sayaka, Hirono Keiichi, Ichida Fukiko, Taguchi Masa |
[Population pharmacokinetic/pharmacodynamic modeling of warfarin by nonlinear mixed effects model]. Yao xue xue bao = Acta pharmaceutica Sinica 2015 Oct 50 (10): 1280-4. Lin Rong-fang, Lin Wei-wei, Wang Chang-lian, Huang Pin-fang, Fang Su-j |
Association of Genetic Polymorphisms of CYP2C9 and VKORC1 with Bleeding Following Warfarin: A Case-Control Study. Current clinical pharmacology 2016 Jan . Thatte Urmi |
Influence of NR3C1 and VDR polymorphisms on stable warfarin dose in patients with mechanical cardiac valves. International journal of cardiology 2017 Jun 236 393-397. Lee Kyung Eun, Chung Jee Eun, Yi Boram, Cho Yoon Jeong, Kim Hyun Jeong, Lee Gwan Yung, Kim Joo Hee, Chang Byung Chul, Gwak Hye S |
Polymorphisms of vitamin K-related genes (EPHX1 and VKORC1L1) and stable warfarin doses. Gene 2017 Oct . Chung Jee-Eun, Lee Kyung Eun, Chang Byung Chul, Gwak Hye S |
Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations. Clinical pharmacokinetics 2019 3 58 (8): 1077-1089. Ohara Minami, Suzuki Yasuhiko, Shinohara Saki, Gong Inna Y, Schmerk Crystal L, Tirona Rommel G, Schwarz Ute I, Wen Ming-Shien, Lee Ming Ta Michael, Mihara Kiyoshi, Nutescu Edith A, Perera Minoli A, Cavallari Larisa H, Kim Richard B, Takahashi Haru |
Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients. Molecular diagnosis & therapy 2021 8 25 (6): 735-755. Hirata Thiago Dominguez Crespo, Dagli-Hernandez Carolina, Genvigir Fabiana Dalla Vecchia, Lauschke Volker Martin, Zhou Yitian, Hirata Mario Hiroyuki, Hirata Rosario Dominguez Cres |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: